Nanoscope s Optical Gene Therapies to be Featured at Optogenetics and Optical Manipulation 2021 Conference
Company s President Samarendra Mohanty will co-chair the conference, which is part of the SPIE Photonics West Digital Forum
News provided by
Share this article
Share this article
BEDFORD, Texas, March 5, 2021 /PRNewswire/ Researchers of Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for treatment of retinal diseases, will make multiple scientific presentations featuring its groundbreaking research on optical gene delivery and opsin based neuromodulation therapy at the Optogenetics and Optical Manipulation 2021 virtual conference, March 6 – 11, 20201.
Nanoscope President Samarendra Mohanty, Ph.D., is serving as a co-chair of the event, which is part of SPIE Photonics West s week long series of online conferences and industry programs. SPIE is an international society for optics and photonics dedicated to advancing light-bas